Speciality Medicines’ IPO opens Friday, aiming to raise Rs 29 crore with a flat 0% grey market premium, indicating cautious investor sentiment. The company, operating in niche speciality pharmaceuticals, plans to use IPO proceeds for R&D, international registrations, and working capital. Investors are advised to monitor subscription demand and institutional participation.
